BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23335524)

  • 1. Hepatic arterial infusion of oxaliplatin, 5-fluorouracil and leucovorin in patients with liver metastases from colorectal carcinoma.
    Melichar B; Ferko A; Krajina A; Rousková L; Dvorák J; Svébisova H; Neoral C; Köcher M; Malirová E; Paral J
    J BUON; 2012; 17(4):677-83. PubMed ID: 23335524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
    Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M;
    J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases.
    Neyns B; Van Nieuwenhove Y; Aerts M; Fontaine C; Vermeij J; Schallier D; Decoster L; De Mey J; Vandenbroucke F; Hoorens A; Delvaux G; De Gréve J
    Anticancer Res; 2006; 26(1B):611-9. PubMed ID: 16739329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
    Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM
    Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
    Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M
    Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases.
    Goéré D; Deshaies I; de Baere T; Boige V; Malka D; Dumont F; Dromain C; Ducreux M; Elias D
    Ann Surg; 2010 Apr; 251(4):686-91. PubMed ID: 20224373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H; Ozaki T; Shiina M
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
    Del Freo A; Fiorentini G; Sanguinetti F; Muttini MP; Pennucci C; Mambrini A; Pacetti P; Della Seta R; Lombardi M; Torri T; Cantore M
    In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.
    Samaras P; Breitenstein S; Haile SR; Stenner-Liewen F; Heinrich S; Feilchenfeldt J; Renner C; Knuth A; Pestalozzi BC; Clavien PA
    Ann Surg Oncol; 2011 Jul; 18(7):1924-31. PubMed ID: 21207165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.
    Guthoff I; Lotspeich E; Fester C; Wallin I; Schatz M; Ehrsson H; Kornmann M
    Anticancer Res; 2003; 23(6D):5203-8. PubMed ID: 14981990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatic arterial infusion of low-dose leucovorin/5-FU chemotherapy for unresectable hepatic metastases from colorectal cancer].
    Fujimoto T; Yoshimatsu K; Yokomizo H; Umehara A; Watanabe K; Ohtani T; Matsumoto A; Ohsawa G; Ishibashi K; Ogawa K
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1838-40. PubMed ID: 17212122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of a Phase I/II Trial of Hepatic Arterial Infusion of Oxaliplatin Combined with Intravenous 5-Fluorouracil and l-Leucovorin in Patients with Unresectable Liver Metastases from Colorectal Cancer After Systemic Chemotherapy Failure.
    Sato Y; Inaba Y; Ura T; Nishiofuku H; Yamaura H; Kato M; Takahari D; Tanaka T; Muro K
    J Gastrointest Cancer; 2018 Jun; 49(2):132-137. PubMed ID: 28058527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy.
    Pilati P; Mammano E; Mocellin S; Tessari E; Lise M; Nitti D
    Anticancer Res; 2009 Oct; 29(10):4139-44. PubMed ID: 19846962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
    Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
    Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prehepatectomy chemotherapy using hepatic artery infusion plus systemic chemotherapy for liver metastases from colorectal cancer].
    Tanaka K; Kumamoto T; Nojiri K; Mori R; Matsuyama R; Takeda K; Ota M; Akiyama H; Ichikawa Y; Endo I
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2267-70. PubMed ID: 21224543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
    Kemeny N; Jarnagin W; Paty P; Gönen M; Schwartz L; Morse M; Leonard G; D'Angelica M; DeMatteo R; Blumgart L; Fong Y
    J Clin Oncol; 2005 Aug; 23(22):4888-96. PubMed ID: 16009951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of hepatic arterial infusion of oxaliplatin plus intravenous irinotecan, leucovorin and fluorouracil in colorectal cancer with inoperable hepatic metastasis.
    Volovat SR; Volovat C; Negru SM; Danciu M; Scripcariu V
    J Chemother; 2016 Jun; 28(3):235-41. PubMed ID: 26018108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of hepatic arterial infusion chemotherapy with 5-FU and leucovorin for unresectable liver metastases from colorectal cancer].
    Yamashita K; Urakami A; Kubota H; Nagatsuka R; Murakami H; Kawabe Y; Higashida M; Hirabayashi Y; Mikami Y; Ikeda M; Fuchimoto M; Yamamura M; Oka Y; Okumura H; Iki K; Matsumoto H; Imai S; Hirai T; Tsunoda T
    Gan To Kagaku Ryoho; 2008 Jan; 35(1):71-6. PubMed ID: 18195531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
    Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
    Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.